Related Experiment Video

Updated: Jul 18, 2026

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Peptido-targeting of the mitochondrial transition pore complex for therapeutic apoptosis induction

Aurélien Deniaud1, Johan Hoebeke, Jean-Paul Briand

  • 1CNRS UMR 8159, Université de Versailles / St Quentin, 45, avenue des Etats-Unis, 78035 Versailles, France.

Current Pharmaceutical Design
|December 16, 2006
PubMed

Insights

The mitochondrial permeability transition pore complex (PTPC) regulates cell death and homeostasis. Targeting PTPC with peptides offers a novel therapeutic strategy for diseases linked to its dysfunction.

Area of Science:

  • Mitochondrial biology
  • Cell death pathways
  • Biochemistry

Background:

  • The permeability transition pore complex (PTPC) is crucial for mitochondrial homeostasis and the intrinsic apoptosis pathway.
  • PTPC integrates various death signals, including intracellular changes and protein translocations.
  • Its deregulation is implicated in major human pathologies.

Purpose of the Study:

  • To review the dual functions of PTPC.
  • To explore PTPC's role in diverse pathologies.
  • To discuss peptide-based therapeutic targeting of PTPC.

Main Methods:

  • Literature review of PTPC functions and pathologies.
  • Analysis of PTPC's role in apoptosis coordination.
  • Exploration of therapeutic strategies targeting PTPC.

Main Results:

  • PTPC coordinates mitochondrial membrane permeabilization and protein release during apoptosis.
  • PTPC deregulation is linked to cancer, neurodegeneration, ischemia/reperfusion, aging, and hepatotoxicity.
  • PTPC exhibits both pro- and anti-apoptotic functions.

Conclusions:

  • PTPC is a key regulator of mitochondrial function and cell fate.
  • PTPC's involvement in pathology highlights its therapeutic potential.
  • Peptide-based modulation of PTPC represents an innovative therapeutic avenue.

More Related Videos

Simultaneous Measurement of Mitochondrial Calcium and Mitochondrial Membrane Potential in Live Cells by Fluorescent Microscopy08:43

Simultaneous Measurement of Mitochondrial Calcium and Mitochondrial Membrane Potential in Live Cells by Fluorescent Microscopy

Published on: January 24, 2017

Related Concept Videos

Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Mitochondrial Precursor Proteins01:39

Mitochondrial Precursor Proteins

Mitochondrial precursors are partially unfolded or loosely folded polypeptide chains. Newly synthesized precursors are inhibited from spontaneously folding into their native conformation by the cytosolic chaperones, heat shock proteins 70 (Hsp70), and mitochondrial import stimulation factors (MSFs). Precursors bound to MSFs are guided to the TOM70-TOM37 receptors, while precursors bound to Hsp70  chaperones are targetted to TOM20-TOM22 receptor complexes.
Most of the mitochondrial precursors...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Energy to Drive Translocation01:37

Energy to Drive Translocation

Mitochondrial protein import is powered by two distinct energy sources: ATP hydrolysis and electrochemical potential across the inner membrane. Newly synthesized precursors are bound by cytosolic chaperones of the Hsp70 family, which guide them to the import receptors on the mitochondrial surface. Utilizing the energy of ATP hydrolysis, Hsp70 chaperones transfer these precursors to the TOM receptors on the mitochondrial outer membrane.
Generally, polypeptides are unfolded by two distinct...
Mitochondrial Protein Sorting01:39

Mitochondrial Protein Sorting

Mitochondria are double-membrane organelles of the eukaryotes involved in cellular metabolism, signaling, ATP synthesis, and programmed cell death.  Each of these processes requires specific proteins and enzymes that must be correctly sorted to the right mitochondrial subcompartment for the proper functioning of the organelle.
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...